Enovix Q4 2022 revenue $1.1M, net loss $11.2M; guides 180K cells in 2023

Enovix Corp

2022-FY EPS reported -$0.82 revenue$6,202,000

Q4 2022 revenue $1.1M (service); GAAP net loss $11.2M ($0.07/share); Non-GAAP net loss $29.2M ($0.19/share).
Shipped 4,442 cells in Q4, exceeding internal goal; volume-weighted yield 42.9% (Q3: 16.4%).
Revenue funnel Active Design/Design Win grew 58% sequentially to $669M from $423M.
Guides Q1 2023 production of 9,000 cells (double Q4); full-year 2023 target 180,000 wearable-size cells.
2023 capex guidance $120M; net cash $322.9M; new COO Ajay Marathe appointed.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Enovix Corp reported financial results for fourth fiscal quarter and fiscal year ended January 1, 2023.

Period: fourth fiscal quarter and fiscal year ended January 1, 2023
Result: reported results

Exact text from the filing

On February 22, 2023, Enovix Corporation released its financial results for the fourth fiscal quarter and fiscal year ended January 1, 2023

View on SEC.gov

3 earnings releases filed in the last 30 days. Browse all earnings releases →

Enovix Corp filing history →

Source: SEC EDGAR

accession 0001828318-23-000059

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.